As reported today in Bloomberg News (9/27, Gokhale) “Urine Spills Staining Image of Wockhardt’s Generic Drugs,” the U.S. Food and Drug Administration inspected the generic drugmaker Wockhardt Ltd.’s factory in India and found serious quality violations including “urine spilling over open drains, soiled uniforms and mold growing in a raw-material storage area.” This factory makes metoprolol, a generic version of the popular heart pill sold by London-based AstraZeneca Plc under the brand name Toprol-XL.
The factory is part of India’s generic drug industry, which per India’s Department of Commerce exported $14.6 billion of medicines last year. In fact, more than one in seven generic drugs bought in the U.S. are Indian-made, as estimated by the country’s Commerce Department.
Zoll, Kranz & Borgess, LLC (“ZKB”) specializes in assisting individuals injured or killed from dangerous, defective or contaminated medical drugs and devices. For more information, contact our pharmaceutical drug and device litigation attorneys by calling toll-free 888-841-9623.